Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Clavijo

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|May 18, 2010
SERS and theoretical studies of arginineA E Aliaga, C Garrido, P Leyton, et al.
Biopolymers|September 28, 2010
Surface-enhanced Raman scattering and theoretical studies of the C-terminal peptide of the β-subunit human chorionic gonadotropin without linked carbohydratesA E Aliaga, T Aguayo, C Garrido, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|July 5, 2014
Surface enhanced Raman scattering study of the antioxidant alkaloid boldine using prismatic silver nanoparticlesM A Herrera, G P Jara, R Villarroel, et al.
Oncoimmunology|February 6, 2018
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiationMegan Morisada, Paul E Clavijo, Ellen Moore, et al.
Oncoimmunology|June 15, 2018
Nanocomplex-based <i>TP53</i> gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanismsEllen C Moore, Lillian Sun, Paul E Clavijo, et al.
Communications Biology|December 21, 2021
Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypesCem Sievers, Yvette Robbins, Ke Bai, et al.
Journal for Immunotherapy of Cancer|August 31, 2021
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosisYvette Robbins, Jay Friedman, Paul E Clavijo, et al.
Journal for Immunotherapy of Cancer|May 5, 2019
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosisClint T Allen, Sunmin Lee, Scott M Norberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer ModelsSarah Greene, Yvette Robbins, Wojciech K Mydlarz, et al.
Frontiers in Immunology|August 28, 2023
Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesisNozomi Sakakibara, Paúl E Clavijo, Cem Sievers, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|May 18, 2010
SERS and theoretical studies of arginineA E Aliaga, C Garrido, P Leyton, et al.
Biopolymers|September 28, 2010
Surface-enhanced Raman scattering and theoretical studies of the C-terminal peptide of the β-subunit human chorionic gonadotropin without linked carbohydratesA E Aliaga, T Aguayo, C Garrido, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|July 5, 2014
Surface enhanced Raman scattering study of the antioxidant alkaloid boldine using prismatic silver nanoparticlesM A Herrera, G P Jara, R Villarroel, et al.
Oncoimmunology|February 6, 2018
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiationMegan Morisada, Paul E Clavijo, Ellen Moore, et al.
Oncoimmunology|June 15, 2018
Nanocomplex-based <i>TP53</i> gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanismsEllen C Moore, Lillian Sun, Paul E Clavijo, et al.
Communications Biology|December 21, 2021
Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypesCem Sievers, Yvette Robbins, Ke Bai, et al.
Journal for Immunotherapy of Cancer|August 31, 2021
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosisYvette Robbins, Jay Friedman, Paul E Clavijo, et al.
Journal for Immunotherapy of Cancer|May 5, 2019
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosisClint T Allen, Sunmin Lee, Scott M Norberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer ModelsSarah Greene, Yvette Robbins, Wojciech K Mydlarz, et al.
Frontiers in Immunology|August 28, 2023
Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesisNozomi Sakakibara, Paúl E Clavijo, Cem Sievers, et al.
Pageof 6